| pubmed-article:1304791 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1304791 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:1304791 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:1304791 | lifeskim:mentions | umls-concept:C0041466 | lld:lifeskim |
| pubmed-article:1304791 | lifeskim:mentions | umls-concept:C0002680 | lld:lifeskim |
| pubmed-article:1304791 | lifeskim:mentions | umls-concept:C0008168 | lld:lifeskim |
| pubmed-article:1304791 | lifeskim:mentions | umls-concept:C0038665 | lld:lifeskim |
| pubmed-article:1304791 | lifeskim:mentions | umls-concept:C0312418 | lld:lifeskim |
| pubmed-article:1304791 | lifeskim:mentions | umls-concept:C0370215 | lld:lifeskim |
| pubmed-article:1304791 | lifeskim:mentions | umls-concept:C0036667 | lld:lifeskim |
| pubmed-article:1304791 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:1304791 | pubmed:dateCreated | 1993-7-13 | lld:pubmed |
| pubmed-article:1304791 | pubmed:abstractText | A trial of Sulbactam/Ampicillin in treatment of typhoid fever was carried out while in-vitro sensitivity of the drug was compared with chloramphenicol. Sulbactam/Ampicillin was found to be effective in 11 out of 12 patients who received the drug. The 1 patient who failed to respond had intestinal perforation with peritonitis. No side effects were encountered. The in-vitro study showed that 91.7% of the isolates were sensitive to sulbactam/ampicillin compared to 75% sensitivity to chloramphenicol. The difference was however not statistically significant (P < 0.05). It is concluded that sulbactam/ampicillin is effective and safe in the treatment of typhoid infection. | lld:pubmed |
| pubmed-article:1304791 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1304791 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1304791 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1304791 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1304791 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1304791 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1304791 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1304791 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1304791 | pubmed:issn | 0189-160X | lld:pubmed |
| pubmed-article:1304791 | pubmed:author | pubmed-author:OnadekoB OBO | lld:pubmed |
| pubmed-article:1304791 | pubmed:author | pubmed-author:OyeleseA OAO | lld:pubmed |
| pubmed-article:1304791 | pubmed:author | pubmed-author:AwoteduA AAA | lld:pubmed |
| pubmed-article:1304791 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1304791 | pubmed:volume | 11 | lld:pubmed |
| pubmed-article:1304791 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1304791 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1304791 | pubmed:pagination | 274-7 | lld:pubmed |
| pubmed-article:1304791 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:1304791 | pubmed:meshHeading | pubmed-meshheading:1304791-... | lld:pubmed |
| pubmed-article:1304791 | pubmed:meshHeading | pubmed-meshheading:1304791-... | lld:pubmed |
| pubmed-article:1304791 | pubmed:meshHeading | pubmed-meshheading:1304791-... | lld:pubmed |
| pubmed-article:1304791 | pubmed:meshHeading | pubmed-meshheading:1304791-... | lld:pubmed |
| pubmed-article:1304791 | pubmed:meshHeading | pubmed-meshheading:1304791-... | lld:pubmed |
| pubmed-article:1304791 | pubmed:meshHeading | pubmed-meshheading:1304791-... | lld:pubmed |
| pubmed-article:1304791 | pubmed:meshHeading | pubmed-meshheading:1304791-... | lld:pubmed |
| pubmed-article:1304791 | pubmed:meshHeading | pubmed-meshheading:1304791-... | lld:pubmed |
| pubmed-article:1304791 | pubmed:meshHeading | pubmed-meshheading:1304791-... | lld:pubmed |
| pubmed-article:1304791 | pubmed:meshHeading | pubmed-meshheading:1304791-... | lld:pubmed |
| pubmed-article:1304791 | pubmed:meshHeading | pubmed-meshheading:1304791-... | lld:pubmed |
| pubmed-article:1304791 | pubmed:meshHeading | pubmed-meshheading:1304791-... | lld:pubmed |
| pubmed-article:1304791 | pubmed:meshHeading | pubmed-meshheading:1304791-... | lld:pubmed |
| pubmed-article:1304791 | pubmed:articleTitle | Clinical trial of sulbactam/ampicillin in the treatment of typhoid fever, and in-vitro sensitivity of isolates to sulbactam/ampicillin and chloramphenicol. | lld:pubmed |
| pubmed-article:1304791 | pubmed:affiliation | Department of Medicine, University College Hospital, Ibadan. | lld:pubmed |
| pubmed-article:1304791 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:1304791 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:1304791 | pubmed:publicationType | Comparative Study | lld:pubmed |
